Montauk Renewables (MNTK) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 Mar, 2026Executive summary
Revenues for 2025 were $176.4 million, remaining flat year-over-year, with a 1.0% increase in RNG production and a 20.5% rise in RIN volumes sold.
Net income for 2025 was $1.7 million, down 82% from $9.7 million in 2024, reflecting higher expenses and lower realized RIN prices.
Major capital projects included commissioning the Second Apex RNG Facility, expanding Pico digestion capacity, and beginning commissioning of the Turkey, NC facility with a $200 million investment.
Adjusted EBITDA for 2025 was $35.6 million, down 16.5% year-over-year; EBITDA was $32.3 million, down 21.2%.
Completed a $200 million senior credit facility in March 2026, restructuring existing debt and supporting growth initiatives.
Financial highlights
Operating income dropped to $0.9 million in 2025 from $16.1 million in 2024.
RNG segment revenues were $155.7 million, down 1.4% year-over-year; renewable electricity revenues were $17.2 million, down 2.9%.
Average realized RIN price in 2025 was $2.33, down 29% from $3.28 in 2024.
Operating and maintenance expenses for RNG facilities rose 10.7% to $59.1 million; for electricity facilities, up 15.3% to $14.7 million.
Cash and cash equivalents at year-end were $23.8 million, down from $45.6 million in 2024.
Outlook and guidance
2026 RNG production volumes expected between 5.8–6.1 million MMBtu, with revenues of $175–$190 million.
Renewable electricity production forecasted at 195,000–207,000 MWh, with revenues of $35–$41 million.
Growth in 2026 expected from full-year realization of 2025 investments and commissioning of the Turkey, NC project.
Major capital projects underway include Bowerman, Tulsa, and Rumpke RNG facilities, with expected commissioning between 2027 and 2028.
Guidance reflects both production and potential RIN price variability.
Latest events from Montauk Renewables
- Q2 revenue dropped 18.6% on delayed RIN sales, but 2024 guidance and project pipeline remain strong.MNTK
Q2 20241 Feb 2026 - Q3 2024 revenue up 18.4% and net income up 31.8%, but project delays persist.MNTK
Q3 202414 Jan 2026 - Net income fell 34.9% to $9.7M on flat revenue, with 2025 RNG revenue guidance at $150–$170M.MNTK
Q4 202426 Dec 2025 - Director elections, auditor ratification, and strategic growth initiatives highlight the 2025 meeting.MNTK
Proxy Filing1 Dec 2025 - Shareholders to elect two directors and ratify Grant Thornton LLP as auditor at the annual meeting.MNTK
Proxy Filing1 Dec 2025 - Revenue up 9.8%, but net loss and regulatory delays challenge outlook; major capex planned.MNTK
Q1 202526 Nov 2025 - Q2 2025 revenue rose 4.1% but net loss widened on lower RIN prices and higher costs.MNTK
Q2 202523 Nov 2025 - Q3 2025 revenue and net income fell sharply on lower RIN sales and prices; capex remains high.MNTK
Q3 202513 Nov 2025